Clinical trial · Observational
Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts
NCT03522090CI-TRIAL-00032860unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a study comparing routine inclusion of the lower neck in initial CT thorax in patients with suspected lung cancer to not including it. The study aims to assess whether such an intervention reduces the number of invasive investigations required to achieve a final diagnosis and clinical stage and whether it improves the detection of cervical lymph nodes involvement by lung cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Supraclavicular Lymphadenopathy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lower neck CT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- No neck CT
- description
- Cohort of patients with suspected lung cancer where the lower neck is not routinely included in CT
- interventionNames
- Diagnostic Test: lower neck CT
- label
- Neck CT
- description
- Cohort of patients with suspected lung cancer where the lower neck is routinely included in CT
- interventionNames
- Diagnostic Test: lower neck CT
Primary outcomes (1)
- measure
- Proportion of pathologically confirmed malignant supraclavicular lymph node
- timeFrame
- 60 days from initial CT
- description
- evidence of malignancy consistent with lung cancer on fine needle aspiration or core biopsy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female age \> 18 years * Pathologically confirmed primary lung cancer * Intrathoracic N2 and or N3 disease on CT defined as lymph node with short diameter \> 10 mm Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.